SS-31

This foundational review by Hazel Szeto summarizes the design rationale and mechanism of the Szeto-Schiller (SS) peptide family, with SS-31 (D-Arg-Dmt-Lys-Phe-NH2) characterized in detail. The alternating positive-charge / aromatic-residue motif drives a membrane-potential-independent accumulation in the inner mitochondrial membrane, where SS-31 binds selectively to cardiolipin through a combination of electrostatic and hydrophobic interactions. By associating with cardiolipin, SS-31 stabilizes the cytochrome c–cardiolipin complex, suppresses the peroxidase activity that cardiolipin can otherwise impart to cytochrome c under stress, and preserves the structure of mitochondrial cristae. Downstream, the review summarizes in vitro and animal-model data showing preserved electron transport chain assembly, restored ATP synthesis, and reduced reactive oxygen species under conditions of mitochondrial stress.

Mitochondria are the parts of a cell that generate energy. Their inner membrane contains a special fat called cardiolipin that holds the energy-generating machinery in the right shape. When mitochondria are stressed, cardiolipin can start damaging the very proteins it normally supports. SS-31 acts like a protective patch — it sticks to cardiolipin, keeps the energy machinery properly assembled, and reduces the damaging side reactions. This 2014 paper by Dr. Szeto, who originally designed the peptide, lays out how SS-31 works and why it was the first compound of its kind.

This study examined SS-31 in models of ischemia and reperfusion injury, where mitochondria are damaged by oxygen deprivation followed by re-oxygenation. Using isolated mitochondria, the authors demonstrated direct binding of SS-31 to cardiolipin and showed that SS-31 preserved the architecture of cristae after ischemic insult. In an in vivo rat model of renal ischemia/reperfusion, SS-31 administration was associated with restored ATP production, preserved respiratory chain supercomplex assembly, and reduced markers of oxidative damage. The authors propose that SS-31's protective effect derives from its ability to dock onto cardiolipin and shield the electron transport chain from the cycle of oxidative damage that follows ischemia.

When tissue loses blood flow and then gets it back — for example during a heart attack or kidney injury — the sudden return of oxygen can paradoxically damage mitochondria. The damaged mitochondria then leak harmful molecules and fail to produce energy. In this study, researchers showed that SS-31 binds to cardiolipin in the inner mitochondrial membrane and helps keep the energy-generating chain intact during this stress. In a rat kidney model, mitochondria from animals given SS-31 were able to make ATP again much faster than untreated controls. This work helped support translational interest in SS-31 for ischemia-related research.